First successful lung transplantation for sickle cell disease with severe pulmonary arterial hypertension and pulmonary veno-occlusive disease

Pulmonary Circulation

Volumn 3, Issue 4, 2013, Pages 952-958

  Patricia George, M ^a   Novelli, Enrico M ^a   Shigemura, Norihisa ^a   Simon, Marc A ^a   Feingold, Brian ^a,b   Krishnamurti, Lakshmanan ^a,b   Morrell, Matthew R ^a   Gries, Cynthia G ^a   Haider, Syed ^a   Johnson, Bruce A ^a   Crespo, Maria M ^a   Bhama, Jay K ^a   Bermudez, Christian ^a   Yousem, Samuel A ^a   Toyoda, Yoshiya ^c   Champion, Hunter C ^a   Pilewski, Joseph M ^a   Gladwin, Mark T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lung transplantation; Pulmonary arterial hypertension; Pulmonary veno occlusive disease; Sickle cell disease

Indexed keywords

EID: 84959341283     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.1086/674749     Document Type: Article

References (33)

1. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 2010;376:2018-2031.
2. Gladwin MT. Prevalence, risk factors and mortality of pulmonary hypertension defined by right heart catheterization in patients with sickle cell disease. Expert Rev Hematol 2011; 4:593-596.
3. Sachdev V, Kato GJ, Gibbs JSR, Barst RJ, Machado RF, Nouraie M, Hassell KL, et al. Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom. Circulation 2011;124:1452-1460.
4. Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, Habibi A, et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med 2011;365:44-53.
5. Fonseca GH, Souza R, Salemi VM, Jardim CV, Gualandro SF. Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease. Eur Respir J 2012;39:112-118.
6. Machado RF, Barst RJ, Yovetich NA, Hassell KL, Kato GJ, Gordeuk VR, Gibbs JSR, et al. Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood 2011;118: 855-864.
7. Yousafzai SM, Ugurlucan M, Al Radhwan OA, Al Otaibi AL, Canver CC. Open heart surgery in patients with sickle cell hemoglobinopathy. Circulation 2010;121:14-19.
8. Brennan DC, Lippmann BJ, Shenoy S, Lowell JA, Howard TK, Flye MW. Living unrelated renal transplantation for sickle cell nephropathy. Transplantation 1995;59:794-795.
9. Nath J, McDaid J, Bentall A, Ball S, Ready AR, Inston NG. Sickle cell and renal transplant: a national survey and literature review. Exp Clin Transplant 2012;10:1-7.
10. Audard V, Grimbert P, Kirsch M, Habibi MA, Lang P, Rémy P, Abbou C, et al. Successful combined heart and kidney transplantation in a patient with sickle-cell anemia. J Heart Lung Transplant 2006;25:993-996.
11. O’Rourke EJ, Laing CM, Khan AU, Hussain R, Standish RA, Buscombe JR, Hilson AJW, Harber M. The case: allograft dysfunction in a patient with sickle cell disease. Kidney Int 2008;74:1219-1220.
12. Chatterjee SN. National study in natural history of renal allografts in sickle cell disease or trait: a second report. Transplant Proc 1987;19:33-35.
13. Chatterjee SN. National study on natural history of renal allografts in sickle cell disease or trait. Nephron 1980;25: 199-201.
14. Ojo AO, Govaerts TC, Schmouder RL, Leichtman, AB, Leavey SF, Wolfe RA, Held PJ, Port FK, Agodoa LY. Renal transplantation in end-stage sickle cell nephropathy. Transplantation 1999;67:291-295.
15. Scheinman JI. Sickle cell disease and the kidney. Nat Rev Nephrol 2009;5:78-88.
16. Montgomery R, Zibari G, Hill GS, Ratner LE. Renal transplantation in patients with sickle cell nephropathy. Transplantation 1994;58:618-620.
17. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med 2000;342:1855-1865.
18. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, Pegelow C, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 1995;333:206-213.
19. Hirst C, Williamson L. Preoperative blood transfusions for sickle cell disease. Cochrane Database Syst Rev 2012; (1): CD003149. afrani ES, et al. Transplantation for liver failure in patients with sickle cell disease:
20. Hurtova M, Bachir D, Lee K, Calderaro J, Decaens T, Kluger MD, Z challenging but feasible. Liver Transplant 2011;17:381-392.
21. Mekeel KL, Langham MR Jr., Gonzalez-Peralta R, Fujita S, Hemming AW. Liver transplantation in children with sickle cell disease. Liver Transplant 2007;13:505-508.
22. Firth PG, Head CA. Sickle cell disease and anesthesia. Anesthesiology 2004;101:766-785.
23. Nagpal KC, Asdourian GK, Goldbaum MH, Raichand M, Goldberg MF. The conjunctival sickling sign, hemoglobin S, and irreversibly sickled erythrocytes. Arch Ophthalmol 1977;95:808-811.
24. Vichinsky EP, Luban NL, Wright E, Olivieri N, Driscoll C, Pegelow CH, Adams RJ. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086-1092.
25. Magee BA, Martin J, Cole MP, Morris KG, Courtney AE. Effects of HLA-matched blood transfusion for patients awaiting renal transplantation. Transplantation 2012;94:1111-1116.
26. Obrador GT, Macdougall IC. Effect of red cell transfusions on future kidney transplantation. Clin J Am Soc Nephrol 2013; 8:852-860.
27. Mason DP, Little SG, Nowicki ER, Batizy LH, Murthy SC, McNeill AM, Budev MM, Mehta AC, Pettersson GB, Blackstone EH. Temporal pattern of transfusion and its relation to rejection after lung transplantation. J Heart Lung Transplant 2009;28:558-563.
28. Jackson A, McSherry C, Butters K, Diko M, Almond PS, Matas AJ, Reinsmoen NL. Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity. Hum Immunol 1997;55:148-153.
29. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
30. Miller ST, Wright E, Abboud M, Berman B, Files B, Scher CD, Styles L, Adams RJ. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr 2001;139:785-789.
31. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-1322.
32. Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood 2010;115:2354-2363.
33. Lee JC, Christie JD. Primary graft dysfunction. Clin Chest Med 2011;32:279-293.